Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP690128.RAinvJtxTyrHbPf_pKAl-hN3jAd0FrN7uikR4vR3S1bbA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP690128.RAinvJtxTyrHbPf_pKAl-hN3jAd0FrN7uikR4vR3S1bbA130_assertion type Assertion NP690128.RAinvJtxTyrHbPf_pKAl-hN3jAd0FrN7uikR4vR3S1bbA130_head.
- NP690128.RAinvJtxTyrHbPf_pKAl-hN3jAd0FrN7uikR4vR3S1bbA130_assertion description "[Our main findings were: (1) the angina patients and particularly those with unstable disease had significantly raised TNFalpha in comparison with the controls, both at the protein and mRNA level; (2) in contrast, the levels of IL-10 were not different in the angina patients in comparison with the healthy controls, resulting in a markedly enhanced TNFalpha:IL-10 ratio, particularly in the unstable angina patients; (3) while exogenously added IL-10 markedly inhibited the release of TNFalpha, IL-8 and tissue factor as well as impairing the gelatinolytic activity and mRNA production of matrix metalloproteinase-9, it enhanced the tissue inhibitor of this metalloproteinase (i.e.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690128.RAinvJtxTyrHbPf_pKAl-hN3jAd0FrN7uikR4vR3S1bbA130_provenance.
- NP690128.RAinvJtxTyrHbPf_pKAl-hN3jAd0FrN7uikR4vR3S1bbA130_assertion evidence source_evidence_literature NP690128.RAinvJtxTyrHbPf_pKAl-hN3jAd0FrN7uikR4vR3S1bbA130_provenance.
- NP690128.RAinvJtxTyrHbPf_pKAl-hN3jAd0FrN7uikR4vR3S1bbA130_assertion SIO_000772 12423320 NP690128.RAinvJtxTyrHbPf_pKAl-hN3jAd0FrN7uikR4vR3S1bbA130_provenance.
- NP690128.RAinvJtxTyrHbPf_pKAl-hN3jAd0FrN7uikR4vR3S1bbA130_assertion wasDerivedFrom befree-20140225 NP690128.RAinvJtxTyrHbPf_pKAl-hN3jAd0FrN7uikR4vR3S1bbA130_provenance.
- NP690128.RAinvJtxTyrHbPf_pKAl-hN3jAd0FrN7uikR4vR3S1bbA130_assertion wasGeneratedBy ECO_0000203 NP690128.RAinvJtxTyrHbPf_pKAl-hN3jAd0FrN7uikR4vR3S1bbA130_provenance.